ArticleJournal of clinical medicine2023

Blood-Derived Systemic Inflammation Markers and Risk of Nodal Failure in Stage Ia Non-Small Cell Lung Cancer: A Multicentric Study.

Federico Tacconi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.